Literature DB >> 26321403

Systemic involvement in localized scleroderma/morphea.

Anna Gorkiewicz-Petkow1, Agnieszka Kalinska-Bienias2.   

Abstract

Localized scleroderma (LoSc), also known as morphea, is a rare fibrosing disorder of the skin and underlying tissues. Sclerosis is mainly limited to the skin, but subcutaneous tissue, fascia, and underlying muscles and bone may also be involved. In some cases, systemic manifestation with visceral abnormalities may occur. Several publications have focused on significant aspects of LoSc: genetics, immunity, epidemiology, scoring systems, and unification of classifications. Clinical studies featuring large cohorts with the disease published by various international study groups have been of great value in furthering the diagnostic and therapeutic management of LoSc.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26321403     DOI: 10.1016/j.clindermatol.2015.05.009

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  3 in total

1.  Morphea in Middle Anatolia, Turkey: a 5-year single-center experience.

Authors:  Isil Bulur; Hilal Kaya Erdoğan; Tekden Karapınar; Zeynep Nurhan Saracoglu
Journal:  Postepy Dermatol Alergol       Date:  2017-08-01       Impact factor: 1.837

2.  From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution.

Authors:  Dilia Giuggioli; Michele Colaci; Emanuele Cocchiara; Amelia Spinella; Federica Lumetti; Clodovero Ferri
Journal:  Dermatol Res Pract       Date:  2018-01-30

3.  Evaluation of mean platelet volume in localized scleroderma.

Authors:  Anil Gulsel Bahali; Ozlem Su; Nazan Emiroglu; Fatma Pelin Cengiz; Mehmet Onur Kaya; Nahide Onsun
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.